The death receptors TRAIL-R1 and TRAIL-R2 are frequently overexpressed in cancer and there is an emerging evidence for their important role in malignant progression, also in the case of pancreatic ductal adenocarcinoma (PDAC). The gene discussed is TNFRSF10A; the disease is pancreatic ductal adenocarcinoma.